nab-Paclitaxel for the treatment of breast cancer: an update across treatment settings

Por Brufsky, Adam
Publicado no Exp Hematol Oncol (2017)

Predictive and Prognostic Value of the 21-Gene Recurrence Score in Hormone Receptor–positive, Node-positive Breast Cancer

Por Brufsky, Adam M.
Publicado em 2014

Current Approaches and Emerging Directions in HER2-resistant Breast Cancer

Por Brufsky, Adam M
Publicado em 2014

Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Por Brufsky, Adam M.
Publicado no Clin Med Insights Oncol (2015)

Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer

Por Puhalla, Shannon, Brufsky, Adam
Publicado em 2008

Decreased risk of breast cancer associated with oral bisphosphonate therapy

Por Mathew, Aju, Brufsky, Adam
Publicado em 2012

Multi-parametric genomic assays for breast cancer: Time for the next generation?

Por Brufsky, Adam, Davidson, Nancy E.
Publicado no Clin Cancer Res (2016)

Metastatic Breast Cancer or Multiple Myeloma? Camouflage by Lytic Lesions

Por Hough, Bruce, Brufsky, Adam, Lentzsch, Suzanne
Publicado em 2010

Adjuvant treatment of HER2-positive breast cancer: winning efforts continue to improve HER2-positive patient outcome long-term

Por Jankowitz, Rachel C, Brufsky, Adam M
Publicado em 2012

Adjuvant endocrine therapy for premenopausal women with breast cancer

Por Puhalla, Shannon, Brufsky, Adam, Davidson, Nancy
Publicado em 2009

A Case of Late-Onset Gemcitabine Lung Toxicity

Por Sherrod, Amanda M., Brufsky, Adam, Puhalla, Shannon
Publicado em 2011

Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment?

Por Steinman, Richard A, Brufsky, Adam M, Oesterreich, Steffi
Publicado em 2012

Can Circulating Tumor Cells Predict Resistance in Metastatic Breast Cancer?

Por Mathew, Aju, Brufsky, Adam M., Davidson, Nancy E.
Publicado no Clin Cancer Res (2015)

Therapeutic approaches for HER2-positive brain metastases: Circumventing the blood–brain barrier

Por Mehta, Ankit I., Brufsky, Adam M., Sampson, John H.
Publicado no Cancer Treat Rev (2012)

Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy

Por Leone, José Pablo, Lee, Adrian V, Brufsky, Adam M
Publicado no Cancer Med (2015)

Patient preferences for chemotherapies used in breast cancer

Por Beusterien, Kathleen, Grinspan, Jessica, Tencer, Thomas, Brufsky, Adam, Visovsky, Constance
Publicado em 2012

A New Method for Predicting Patient Survivorship Using Efficient Bayesian Network Learning

Por Jiang, Xia, Xue, Diyang, Brufsky, Adam, Khan, Seema, Neapolitan, Richard
Publicado em 2014

Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling

Por Wheeler, David S., Barrick, Stacey R., Grubisha, Melanie J., Brufsky, Adam M., Friedman, Peter A., Romero, Guillermo
Publicado em 2010

An Isoform of C/EBPβ, LIP, Regulates Expression of the Chemokine Receptor CXCR4 and Modulates Breast Cancer Cell Migration

Por Park, Bae-Hang, Kook, Sungho, Lee, SeanBong, Jeong, Jong-Hyeon, Brufsky, Adam, Lee, Byeong-Chel
Publicado em 2013

Biomarker profile in breast carcinomas presenting with bone metastasis

Por Bohn, Olga L, Nasir, Irem, Brufsky, Adam, Tseng, George C, Bhargava, Rohit, MacManus, Kim, Chivukula, Mamatha
Publicado em 2009